News archive

Filter by: Reset

October 2020

- October 27, 2020
- Crown Bioscience
Crown Bioscience Increases APAC Capacity with New Facility in Zhongshan, China

CrownBio’s world-leading products and services are used by pharmaceutical and biotech customers across APAC, North America, and Europe to accelerate and de-risk their drug discovery programs.
- October 20, 2020
- KBI Biopharma
JSR Life Sciences Expands its European Gene-to-GMP Biologics Manufacturing Facilities for Selexis and KBI Biopharma i...

The two companies combined will occupy 8,700 square meters in the Stellar 32 campus within Geneva’s ZIPLO (Industrial Zone Plan-les-Ouates).
- October 8, 2020
- Crown Bioscience
Crown Bioscience Invests in Process Excellence with the Appointment of New Vice President of Global Quality

Crown Bioscience today announces the appointment of Pam Shang as vice president for global quality.

- September 2, 2020
- KBI Biopharma
Igyxos and Selexis Enter Service Agreement to Advance Igyxos’ First-In-Class Monoclonal Antibody for the Treatment of...

Under the agreement, Igyxos will utilize Selexis’ proprietary SUREtechnology Platform™ to rapidly develop the research cell banks (RCBs) necessary to advance the program to human trials.

- June 9, 2020
- Crown Bioscience
New NAFLD/NASH Preclinical Model Data to be Presented at ADA 2020

The data will be available at the American Diabetes Association (ADA) 80th Scientific Sessions, as well as CrownBio’s own complementary virtual event.

- May 26, 2020
- Crown Bioscience
Pivotal Preclinical Oncology Platform Expands to Include New Patient-Derived Organoid Models

HUB patient-derived organoids (PDO) added to CrownBio’s unique platform designed to disrupt traditional drug discovery workflows
- May 11, 2020
- MBL
MBL has concluded the license agreement regarding fully human monoclonal antibodies for four (4) infectious diseases

The antibodies are expected to help in treating and preventing pandemic infections including Influenza because of their broadly neutralizing activity.
- May 8, 2020
- MBL
MBL Launches New ELISA-based Companion Diagnostic Kit for Spinal Muscular Atrophy

The MEBCDX AAV9 test kit was therefore developed as a CDx to be used as an aid in selecting anti-AAV9 antibody negative SMA patients for treatment with Zolgensma.

- April 14, 2020
- Crown Bioscience
CrownBio Announces C-Suite Leadership Changes

CrownBio is a leading contract research organization (CRO) in both the drug discovery and biomarker discovery arenas with a range of innovative product portfolios available across sites in Asia, th...
- April 2, 2020
- Crown Bioscience
Crown Bioscience Expands PDX Collection with Acquisition of Unique Models from Leading Academic Medical Centers

Agreements with CoMotion at the University of Washington and Dana-Farber Cancer Institute add new prostate cancer and lymphoma models to the world’s largest PDX collection

- March 23, 2020
- MBL
Medical & Biological Laboratories Co., Ltd. launches real time PCR-based assay kit products for SARS-CoV-2

MBL has begun manufacturing the RUO kit, called FLUOROSEARCH Novel Coronavirus (SARS-CoV-2) Detection Kit, at a capacity of several tens of thousands of tests per month and will begin accepting ord...

10 of 23